Innoveren Scientific Inc., a medical bioscience company that develops technology in regenerative medicine for limb salvage. It is also developing immunotherapies for ovarian cancer, pancreatic cancer, and mesothelioma. The company was formerly known as H-CYTE, Inc. and changed its name to Innoveren Scientific Inc. in July 2023. The company is headquartered in Tampa, Florida.
Innoveren Scientific reported revenue of $453,460 for fiscal year 2022, down 71.9% from fiscal year 2021, and net income of -$10.30 million.
Figures from company filings; latest fiscal year ended December 31, 2022.
No profile data available.